Treatment Advances

July 23, 2025

Ropeginterferon alfa-2b may help manage low-risk and pre-fibrotic MF by improving blood counts, symptoms, and mutation levels.

June 30, 2025

Based on expert research insights, learn how CAR T-cell therapy could become a future treatment for myelofibrosis and who may benefit most.

June 10, 2025

Rusfertide may reduce phlebotomies and improve symptoms in people with polycythemia vera, offering a new at-home treatment option.

May 19, 2025

Explore the latest treatment options for polycythemia vera, including injectables and JAK inhibitors that help manage symptoms and blood counts.

April 30, 2025

Learn from real-world studies on how momelotinib positively impacts myelofibrosis patients' health.

April 01, 2025

Study shows improved survival and lower relapse in MF with BuFlu and thiotepa conditioning before stem cell transplant.

March 03, 2025

Discover how the new anti-inflammatory treatment CK0804 combined with ruxolitinib is improving myelofibrosis patient outcomes.

February 11, 2025

Learn how pacritinib and momelotinib help myelofibrosis patients with low blood counts, anemia, and platelet issues, based on recent study findings.

January 29, 2025

Is age as significant a barrier as previously thought to receive a stem cell transplant? Learn insights from a myelofibrosis study.

November 22, 2024

Learn about ruxolitinib (Jakafi), a non-chemotherapy treatment for people with polycythemia vera (PV).